AU Optronics : To lift non-competition restrictions on new Directors and their representatives at AUO 2022 Annual General Shareholders' Meeting

Close

Today's Information

Provided by: AU Optronics Corp.
SEQ_NO	3	Date of announcement	2022/06/17	Time of announcement	16:29:35
Subject	To lift non-competition restrictions on new Directors and their representatives at AUO 2022 Annual General Shareholders' Meeting
Date of events	2022/06/17	To which item it meets	paragraph 21
Statement	1.Date of the shareholders meeting resolution:2022/06/17 2.Name and title of the director with permission to engage in competitive conduct: (1)Director, Shuang-Lang (Paul) Peng (2)Representative of AUO Foundation, Frank Ko (3)Institutional director, Qisda Corporation (4)Representative of Qisda Corporation, Han-Chou (Joe) Huang (5)Representative of Ming Hua Investment Company Limited, Chuang-Chuang Tsai (6)Independent Director, Chin-Bing (Philip) Peng (7)Independent Director, Yen-Hsueh Su (8)Independent Director, Chiu-ling Lu (9)Independent Director, Cathy Han 3.Items of competitive conduct in which the director is permitted to engage: (1)Director, Shuang-Lang (Paul) Peng Director, Ennostar Inc. Director, Qisda Corp. (2)Representative of AUO Foundation, Frank Ko Director, Darwin Precisions Corp. Director, ADLINK Technology Inc (3)Institutional director, Qisda Corporation Director, Darfon Electronics Corp. Chairman, Alpha Networks Inc. Chairman, DFI Inc. Chairman, Sysage Technology Co., Ltd. Chairman, BenQ Materials Corp. Director, Topview Optronics Corp. Chairman, Simula Technology Inc. Chairman, Partner Tech Corp. Chairman, Data Image Corporation Director, Aplex Technology Inc. Director, Q.S. Control Corp. Chairman, K2 International Medical Inc. Chairman, BenQ corporation Chairman, Golden Spirit Co., Ltd. Chairman, Darly Venture Inc. Chairman, BenQ Dialysis Technology Corp. Chairman, Qisda Optronics Corp. Chairman, BenQ Biotech (Shanghai) Co.,Ltd Chairman, Qisda Vietnam Co.,Ltd (4)Representative of Qisda Corporation, Han-Chou (Joe) Huang Director, Qisda Corporation Director, Topview Optronics Corp. Chairman, Data Image Corporation Chairman, DIVA Laboratories, Ltd. Chairman, Simula Technology Inc. Chairman, Action Star Technology Co., Ltd. Chairman, Qisda Optronics Corp. Director, Qisda America Corp. (5)Representative of Ming Hua Investment Company Limited, Chuang-Chuang Tsai Director, E Ink Holdings Inc. (6)Independent Director, Chin-Bing (Philip) Peng Independent Director, Apacer Technology Inc. Director, Wistron Corporation Director, Wistron NeWeb Corporation Director, Wistron Information Technology & Services Corporation Chairman, Smart Capital Corporation Supervisors, Allxon Inc. Director, Zigong Art Sharing Co., Ltd. (7)Independent Director, Yen-Hsueh Su Independent Director, TXC Corporation Director, Spotfilms Co., Ltd. Independent Director, The Eslite spectrum Corp. Independent Non-executive Director, Cowell E Holdings Inc. (8)Independent Director, Chiu-ling Lu Independent Director, Chen Full International Co., Ltd. (9)Independent Director, Cathy Han Independent Director, Wiwynn Corporation Independent Director, Apacer Technology Inc. Independent Director, Macroblock, Inc. 4.Period of permission to engage in the competitive conduct: Within the period of serving as Director of the Company. 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): The resolution was adopted by two-thirds or more of the attending shareholders who represent a majority of the total number of the Company's outstanding shares. 6.If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors (if it is not the operator of a Mainland-area enterprise, please enter "N/A" below): Institutional director, Qisda Corporation 7.Company name of the mainland China area enterprise and the director's position in the enterprise: Chairman, BenQ Biotech (Shanghai) Co.,Ltd 8.Address of the mainland China area enterprise: No. 613, 713 Taihua Road, Pudong New District, Shanghai 9.Operations of the mainland China area enterprise: Manufacturing and trading of medical equipment 10.Impact on the company's finance and business:None 11.If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:None 12.Any other matters that need to be specified:None